Norris Medicines Ltd
company logo

Norris Medicines Ltd

Pharmaceuticals
Small Cap

-

- (0%)

Norris Medicines Ltd Performance

-

-

-

-


-

-

-

-

-

Norris Medicines Ltd Fundamentals

12.81Cr

-

-

-

-

-%

-13.56

i buttonClick here to know more about Fundamentals

Norris Medicines Ltd Financials

Norris Medicines Ltd Financialsright-arrow

Norris Medicines Ltd Shareholding Pattern

Norris Medicines Ltd Delivery and Volume

About Norris Medicines Ltd

Norris Medicines Ltd was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on 7th March 1992. The unit expanded

Vimal D Shah

1990

-

NameDesignation
Vimal D ShahManaging Director
Hiten ParikhIndependent Director
S A M AzmathullahIndependent Director
Susmita MahapatraIndependent Director
Prerna KarwaCompany Sec. & Compli. Officer
Vimal ShahAdditional Director
News and Events...

Similar Stocks

What's Trending

Norris Medicines Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Norris Medicines Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Norris Medicines Ltd's share price is ₹12.81 as of 2024-07-25.
Norris Medicines Ltd's P/E ratio is - times as of 2024-07-25.
Norris Medicines Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Norris Medicines Ltd's market capitalization is ₹12.81 Cr as on 2024-07-25.
The current financial records of Norris Medicines Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Norris Medicines Ltd's most recent financial filings, the company has a total asset value of ₹6.53, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Norris Medicines Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Norris Medicines Ltd's 52-week high and low as of 2024-07-25 are ₹13.07 and ₹12.81, respectively.